APA (7th ed.) Citation

Go Tajima, Keiichi Hara, Miyuki Tsumura, Reiko Kagawa, Fumiaki Sakura, Hideo Sasai, . . . Satoshi Okada. (2023). Newborn Screening with (C16 + C18: 1)/C2 and C14/C3 for Carnitine Palmitoyltransferase II Deficiency throughout Japan Has Revealed C12/C0 as an Index of Higher Sensitivity and Specificity. MDPI AG.

Chicago Style (17th ed.) Citation

Go Tajima, Keiichi Hara, Miyuki Tsumura, Reiko Kagawa, Fumiaki Sakura, Hideo Sasai, Miori Yuasa, Yosuke Shigematsu, and Satoshi Okada. Newborn Screening with (C16 + C18: 1)/C2 and C14/C3 for Carnitine Palmitoyltransferase II Deficiency Throughout Japan Has Revealed C12/C0 as an Index of Higher Sensitivity and Specificity. MDPI AG, 2023.

MLA (9th ed.) Citation

Go Tajima, et al. Newborn Screening with (C16 + C18: 1)/C2 and C14/C3 for Carnitine Palmitoyltransferase II Deficiency Throughout Japan Has Revealed C12/C0 as an Index of Higher Sensitivity and Specificity. MDPI AG, 2023.